Evidence map›Paper›PMID 28592703›Full record

ArticleMolecular cancer research : MCR2017

Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.

Rahul Aggarwal, Spencer C Behr, Pamela L Paris, Charles Truillet, Matthew F L Parker, Loc T Huynh, Junnian Wei, Byron Hann, Jack Youngren, Jiaoti Huang and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  6. Review
  7. Quantitative and Qualitative Improvement of Low-Count [Molecular imaging and biology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Quantitative imaging of receptor-ligand engagement in intact live animals.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Rahul AggarwalDepartment of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
Spencer C BehrDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Pamela L ParisHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Charles TruilletDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Matthew F L ParkerDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Loc T HuynhDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Junnian WeiDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Byron HannHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Jack YoungrenDepartment of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
Jiaoti HuangDepartment of Pathology, Duke University, Durham, North Carolina.
Gayatri PremasekharanHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Nimna RanatungaHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Emily ChangDepartment of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
Kenneth T GaoDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Charles J RyanDepartment of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
Eric J SmallDepartment of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
Michael J EvansHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. Michael.Evans@ucsf.edu.
Duke University · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PETR01CA176671 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI EVANS, MICHAEL JOHN, LEWIS, JASON S. · 2013 to 2017
$3.1M
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrinR00CA172695 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EVANS, MICHAEL JOHN · 2014 to 2016
$728k
NCI NIH HHS P30 CA082103NCI NIH HHS R00 CA172695NCI NIH HHS R01 CA176671
6 · The paper itself

Abstract

Noninvasive biomarkers that detect the activity of important oncogenic drivers could significantly improve cancer diagnosis and management of treatment. The goal of this study was to determine whether

Indexed as

Genes, mycHumansMalePositron-Emission TomographyProstatic NeoplasmsTransferrinTransferrin

Identifiers

PMID28592703
PMCPMC5581675
OpenAlexW2622586060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.